2. Prognosis
3. Therapy/Treatment
4. Risk/Harm
Others:
Systematic Review and Meta-analysis
Clinical Guidelines
Penyakit
Hasil uji Ya Tidak Jlh
Ya PB PS PB+PS
Tidak NS NB NB+NS
Jlh PB+NS PS+NB total
PB=positif benar ; PS = positif semu ; NS = negatif semu ; NB = negatif benar
SENSITIVITAS dan SPESIFISITAS
BAKU EMAS
UJI Positif Negatif Jlh
Positif A B A+B
Negatif C D C+D
Jlh A+C B+D A+B+C+D
TABEL 2X2 HASIL UJI DIAGNOSTIK YAITU HASIL YG DIPEROLEH DGN UJI YG
DITELITI DAN DGN HASIL PD PEMERIKSAAN DGN BAKU EMAS.
Sensitivitas = A : (A+C)
Spesifisitas = D : (B+D)
Nilai prediksi positif (Positive Predictive Value ) = A : (A+B)
Nilai prediksi negatif (Negative Predictive Value) = D : (C+D)
PRE-TEST PROBABILITY = PREVALENCE = (A+C ) /
(A+B+C+D)
LR = LIKELIHOOD RATIO
LR+ = SENSITIVITY/(1-SPESIFICITY)
LR- = (1- SENSITIVITY)/SPESIFICITY
Penyakit
Limfoma Non Jlh
limfoma
Hasil uji Positif 65 30 95
Negatif 35 70 105
Jlh 100 100 200
Histopatologi
Ca Non Ca Jlh
Positif 13 4 17
Mammografi Negatif 3 28 31
Jlh 16 32 48
PRE-TEST
LR+: LR-:
SENSITIVITY: SPESIFICITY: PROBABILITY
SENS/ (1-SENS)
A/(A+C) D/(B+D) = PREVALENCE:
(1-SPEC) /SPEC
(A+C ) / (A+B+C+D)
(13/16)X100% 1-(13/16)
(28/32)X100% (13/16) 16/48
/(28/32)
/(1-28/32)
= 81,25%
=87,5% =6,5 = 33,3%
=0,21
PRE TEST ODDS= POST-TEST PROBABILITY=
POST TEST ODDS=
PREVALENCE: POST TEST ODDS:
PRE TEST ODDS X LR+
(1-PREVALENCE) (1+POST TEST ODDS)
Diagnosis
DIAGNOSIS WORKSHEET
Citation:
Additional notes:
Software: CAT Maker……
Thank you…..